China Non Prescription Drug Association visits Yuyue Medical and only one company

Aug 18,2026

Source:

Internet

China Non Prescription Drug Association visits Yuyue Medical and only one company

At Yuyue Medical, President Liu Pei and his delegation visited the company's intelligent manufacturing production line and product display center to understand the company's technological innovation and market layout in areas such as respiratory therapy, blood glucose management, infection control, and emergency equipment. Yu Caihao, Vice President of Yuyue Medical and President of Sales Business Group in China, introduced that as a leading domestic enterprise in home medical devices, Yuyue Medical relies on the global R&D and manufacturing system to build a comprehensive product matrix covering home health and clinical medicine, forming significant brand advantages and market competitiveness. Its products are exported to multiple countries and regions overseas, serving over 300000 medical institutions worldwide and more than 90% of tertiary hospitals in China. President Liu Pei stated that Yuyue Medical has long adhered to innovation driven, deeply rooted in family health, and assisted the public in self-care. It has played a demonstrative and leading role in promoting the digitization and quality of home medical devices.

In just one company, the research team focuses on examining solutions for pharmaceutical intelligent packaging and automated production lines, to gain a detailed understanding of the company's intelligent manufacturing capabilities in serving the pharmaceutical and health consumer goods fields. According to Xu Caiping, Vice President of Only One Company, Only One has been focusing on the research and development of fully automatic packaging equipment in the fields of medicine, health products, dairy products, food, etc. for a long time, serving many of the top 100 pharmaceutical companies in China, empowering the pharmaceutical industry with high-end intelligent equipment to improve quality, efficiency, and compliance in production. President Liu Pei pointed out that pharmaceutical equipment is a key support for ensuring drug quality and improving industry efficiency. Only one company has empowered the modernization of the pharmaceutical industry chain with technological innovation, providing solid equipment support for the high-quality development of the OTC industry.

During the discussion and exchange, President Liu Pei stated that the association will continue to play a bridging role, focus on the development needs of enterprises, strengthen policy docking, standard coordination, and resource integration, support leading enterprises to increase innovation investment, enhance brand influence, promote the deep integration of over-the-counter drugs and home health industry, and better meet the diversified needs of the public in self medication and self-care.

The company leader expressed gratitude for the association's long-term support and introduced the company's development strategy and industrial planning. They communicated on strengthening industry university research cooperation, improving the self-care science popularization system, promoting the deep integration of intelligent manufacturing and the pharmaceutical industry, and expanding the international market. All parties unanimously expressed that they will take this survey as an opportunity to deepen collaborative linkage, jointly promote the standardized, innovative, and international development of over-the-counter drugs and the health industry, and contribute to the construction of a healthy China. Association officials, industry experts, and corporate executives participated in the research activities.

The previous one

Only one company has released its Environmental, Social, and Governance (ESG) report for the year 2025

Next one

Intelligent equipment leads the upgrading of traditional Chinese medicine industry: precise and efficient, intelligent manufacturing for the future